CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 31 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Salt Lake City, Utah, United States and 34 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Salt Lake City, Utah, United States and 215 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Salt Lake City, Utah, United States and 93 other locations
Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood cells). The purpose ...
Phase 1
West Valley City, Utah, United States and 3 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Salt Lake City, Utah, United States and 67 other locations
comprise 2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in patients with primary central nervous system lymphoma...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 41 other locations
Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The secondary objectives are to characterize t...
Phase 1
West Valley City, Utah, United States of America and 1 other location
The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...
Phase 3
Salt Lake City, Utah, United States and 186 other locations
trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two phases. The primary object...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal